BridgeMD
New treatment option for Asthma
Official title Alternate Nostril Breathing With Incentive Spirometry on Lung Function Among Asthma Patients
ClinicalTrials.gov ID: NCT07110116
What this study is testing
- What it's testing
- To compare effects of Alternate Nostril Breathing exercise with incentive spirometer on lung functions (forced vital capacity, forced expiratory volume, and peak expiratory flow rate) in Asthma patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Diagnosed male \& female asthma patients of age 18-60 years.
- Patients with mild to moderate asthma having predicted FEV1 between 60-80%.
- Stable asthma condition without recent exacerbations.
- Able to perform spirometry and follow instructions for the interventions.
- No recent respiratory infections.
You likely can't join if
- Patients with severe asthma (FEV1 \< 60% predicted).
- Patients having respiratory infections, recent exacerbations or other comorbidities.
- Inability to perform breathing exercises or spirometry.
- Patients using medications like oral steroids, beta blockers.
- Pregnant women due to potential risks with breathing exercises.
The study team makes the final eligibility decision.
Where it's taking place
- Abbottābād, Khyber PkahtoonKhwa, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Abbottābād, Khyber PkahtoonKhwa, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.